Waste water resulted from polymer flooding oil recovery generally has a bad impact on the subsequent process of enhanced oil recovery. Separating residual oil from oil/water (O/W) emulsion with suitable kinds of demulsifier is one strategy generally adopted by oil companies. Because of the existence of large amounts of ultrafine oil droplets with the average diameter less than 2 μm, the emulsions can be extremely difficult to break up. To solve this problem, an amine-based dendrimer demulsifier PAMAM (polyamidoamine) was synthesized in this study, and the efficiency of the demulsifier in dealing with O/W emulsions with ultrafine oil droplets was investigated. Because of its strong interfacial activity and relatively good solubility in water, the dendrimer-based demulsifier can easily attach to emulsified oil droplets in a stable diesel-in-water emulsion. The influences of temperature, settling time, and concentration of the demulsifier used on the efficiency of the demulsifier were investigated in detail. The optimal operating condition under which more than 90% oil was removed from the original emulsion by the demulsifier was found. In contrast, less than 2% oil was removed from the emulsion without applying the demulsifier under the same conditions. Micrographs showed that the PAMAM demulsifier could lead to the breakup of diesel-in-water emulsions with ultrafine oil droplets by flocculation and coalescence. The surface tension and interfacial tension at the diesel–water interface were also measured to give a basic understanding of the demulsification mechanism. Though not perfect in dealing with emulsions with the average oil droplets less than 2 μm due to the relatively high demulsifier dosage, its relatively simple synthetic procedure and mild operating conditions showed a great promise in industrial applications with unique advantages over traditional physical methods.

Wetland biomass is an important indicator of wetland ecosystem health. In this study, four dominant vegetation communities (Carex cinerascens, Phalaris arundinacea, Artemisia selengensis, and Miscanthus sacchariflorus) in the Poyang Lake wetland from 2010 to 2016 were classified from Landsat images using spectral information divergence (SID). We combined aboveground biomass (AGB) field measurements and remote sensing data to establish a suitable model for estimating wetland AGB in Poyang Lake, which is on the Ramsar Convention’s list of Wetlands of International Importance. The results showed that (1) overall, the classification accuracy for vegetation pixels across 5 years ranged from 59.1% to 73.7% and (2) the inter-annual and spatial variations in the AGB of the four vegetation types were clear. C. cinerascens had an average AGB density value of 1.28 kg m−2 in Poyang Lake from 2010 to 2016; M. sacchariflorus had the highest AGB density with an average value of 1.39 kg m−2; A. selengensis had almost the same level at 1.26 kg m−2; and P. arundinacea had the lowest AGB density at 0.64 kg m−2. This study provides useful experience for estimating carbon sequestration of vegetation in freshwater wetlands.

No abstract

TP53 plays essential roles in tumor initiation and progression, and is frequently mutated in cancer. However, pharmacological stabilization and reactivation of p53 have not been actively explored for targeted cancer therapies. Herein, we identify a novel Cyclophilin A (CypA) small molecule inhibitor (HL001) that induces non-small cell lung cancer (NSCLC) cell cycle arrest and apoptosis via restoring p53 expression. We find that HL001 stabilizes p53 through inhibiting the MDM2-mediated p53 ubiquitination. Further mechanistic studies reveal that the downregulation of G3BP1 and the induction of reactive oxygen species and DNA damage by HL001 contribute to p53 stabilization. Surprisingly, HL001 selectively suppresses tumor growth in p53 wild-type NSCLC harboring Arg72 homozygous alleles (p53-72R) through disrupting interaction between MDM2 and p53-72R in a CypA-dependent manner. Moreover, combining HL001 with cisplatin synergistically enhance tumor regression in orthotopic NSCLC mouse model. Collectively, this study demonstrates that pharmacologic inhibition of CypA offers a potential therapeutic strategy via specific activation of p53-72R in NSCLC.

PurposeTo explore the feasibility and efficacy of docetaxel plus prednisone for Chinese population with metastatic castration refractory prostate cancer (mCRPC).Patients and methodsA total of 228 patients recruited from 15 centers were randomized to receive 10 cycles of D3P arm (docetaxel: 75 mg/m2, intravenous infusion, every three weeks; Prednisone 10mg orally given daily) or M3P arm (mitoxantrone: 12 mg/m2, intravenous infusion, every three weeks; Prednisone 10mg orally given daily). Primary end point was overall survival, and secondary end points were events progression-free survival (PFS), response rate, response duration. Quality of life (QoL) was also assessed in both treatment groups.ResultsThe median overall survival was 21.88 months in D3P arm and 13.67 months in M3P arm (P = 0.0011, hazard ratio = 0.63, 95% confidence interval, 0.46–0.86). Subgroup analysis was consistent with the results of overall analysis. Events progression-free survival (pain, PSA, tumor and disease) were significantly improved in D3P arm compared with M3P arm. PSA response rate was 35.11% for patients treated by D3P arm and 19.39% for M3P arm (P = 0.0155). Pain response rate was higher in D3P arm (61.11%, P = 0.0011) than in M3P (23.08%) arm. No statistical differences were found between D3P arm and M3P arm for QoL, tumor response rate and response duration of PSA and pain. The tolerability and overall safety of D3P arm were generally comparable to that of M3P arm.ConclusionsCompared with M3P arm, D3P arm significantly prolonged overall survival for the Chinese patients with mCRPC and improved the response rate for PSA and pain.Trial Registration clinicaltrials.gov NCT00436839